Ganoderma lucidum inhibits proliferation and promotes autophagy in breast cancer cell lines with varying hormonal sensitivity by regulating Beclin-1, LC3, and p62

Purpose: The aim of this study was to investigate the role of Ganoderma lucidum (GL) in cell proliferation and autophagy in breast cancer cell lines. Materials and Methods: Cell lines were cultured in vitro and the appropriate dose was determined by the MTT method. In order to show the effect of GL on autophagy in MCF-7 and MDA-MB-231 breast cancer cell lines, Beclin-1, LC3 and p62 expression were examined by immunohistochemistry staining. Additionally, cell cycle analysis was carried out in GL-treated and untreated cells using a cell cycle analysis kit to look into how GL affects cell division. Results: Viability level was significantly reduced in MCF-7 and MDA-MB-231 cells incubated with 40 and 80 μM concentrations of GL for 24 hours. In addition, GL induced the initiation of autophagy in MDA-MB-231 and MCF-7 cells, as evidenced by enhanced levels of Beclin-1, LC3 and p62 expression. At the same time, this study showed that GL induced cell cycle arrest in the G2/M phases. Conclusion: GL has anti-proliferative activity by arresting the cell cycle at the G2/M phase and accelerates cell death by inducing autophagy, particularly in aggressive breast cancers that are resistant to treatment..

Melissa officinalis L. bitkisinin apoptoz ve otofaji yoluyla insan meme kanser hücre hattı üzerine etkisi

Amaç: Bu araştırmanın amacı, Melissa officinalis L. bitkisinin in vitro olarak MCF-7 meme kanseri hücrelerindeki ölüm yollarını nasıl etkilediğini görmektir. Gereç ve Yöntem: Melissa officinalis bitkisinin topraküstü kısımlarından hazırlanan %70 metanolik ekstrenin sitotoksik aktivitesi ve IC50 değerini belirlemek için MCF-7 meme kanseri hücre hattı farklı konsantrasyonlar da ve sürelerde Melissa officinalis’ e maruz bırakılarak MTT analizi yapıldı. Melissa officinalis' in belirlenen IC50 dozunda meme kanseri hücreleri üzerindeki apoptotik etkileri TUNEL yöntemi ile, otofajik etkileri Beclin-1 ve LC3 immünofloresan boyama yöntemi kullanılarak ortaya çıkarıldı. Bulgular: Melissa officinalis’ in, MCF-7 meme kanseri hücreleri üzerindeki etkileri değerlendirildiğinde, MCF-7 meme kanseri hücre hattındaki hücre canlılığını doza ve zamana bağlı bir şekilde azalttığı görüldü. Bunun yanı sıra, apopitozu indüklediği ve otofaji belirteçleri olan Beclin-1 ve LC3 immunreaktivitesini de artırdığı gözlendi. Sonuç: Çalışmadan elde edilen bulgular, Melissa officinalis’in hem apoptoz hem de otofaji hücre ölümü yolları üzerinden MCF-7 meme kanseri hücreleri üzerinde sitotoksik bir etkiye sahip olduğunu göstermiştir. Bu veriler, antitümör etki mekanizmasını aydınlatmak için gerekli olan daha ileri in vitro çalışmalara öncülük edecektir.

Anti-inflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury

BACKGROUND/AIM

Acute lung injury (ALI) is a major cause of death in the intensive care unit. Lipopolysaccharide (LPS) induced lung injury is the most widely used experimental ALI model and provides opportunities for new targeting therapy. In this study, we investigated the effects of tocilizumab, adalimumab, and methylprednisolone in LPS-induced acute lung injury.

MATERIALS AND METHODS

Lung injury was established by intratracheal instillation of LPS. The rats were randomly divided into six groups: LPS, control, and treatment groups (adalimumab, tocilizumab, methylprednisolone, and adalimumab + tocilizumab). Bronchoalveolar lavage (BAL) and lung tissues were collected at 48 h and 96 h following LPS administration from each group. For histological analysis, hematoxylin?eosin (H&E) staining was performed. The sections were obtained for immunohistochemical analysis. IL-6 and TNF-? immunoreactivity were measured.

RESULTS

Intratracheal LPS application resulted in inflammatory cell infiltration of interstitial and alveolar spaces and thickening of the alveolar wall. All treatment groups showed signi?cantly amelioration compared to LPS at 48 h. Interestingly, adalimumab and adalimumab + tocilizumab groups showed a significant amelioration of the lung histoarchitecture, compared to the prednisolone group at 96 h (p=0.028, p=0.025, respectively). Compared to the control group, LPS stimulation resulted in a significant increase in IL-6 and TNF-? immunoreactivity (p<0.001). IL-6 and TNF-? expression were markedly reduced in all treatment groups at 48 h but the reduction was greater in the adalimumab and tocilizumab group than in the steroid. Administration with adalimumab and/or tocilizumab effectively decreased expression of TNF-? (p=0.001) and IL-6 (p<0.001) at 96 h, but prednisolone did not exert an effective decrease (p>0.05).

CONCLUSION

Adalimumab and/or tocilizumab significantly reduce the release of proinflammatory cytokines and improve the tissue inflammation in the experimental model of ALI. Our results suggest that adalimumab and/or tocilizumab have a more potent anti-inflammatory effect on lung injury than the steroid.

The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model

Background/Aim

Cisplatin is a highly effective chemotherapeutic agent used in the treatment of solid organ cancers. Besides its chemotherapeutic effectiveness, cisplatin administration is associated with numerous side effects. Of those, the most clinically significant and common effect is nephrotoxicity. Recent studies reported that oxidative stress and inflammation are probably the most important mechanisms that contribute to the nephrotoxicity. N-acetylcysteine (NAC) is an antioxidant and antiinflammatory agent. In the present study, the effects of NAC on cisplatin-induced nephrotoxicity were investigated.

Materials and methods

Rats were divided into four groups each including eight rats: CONT, NAC-250, CP, and CP+NAC. Rats in experimental groups were treated intraperitoneally (i.p.) with a single dose of cisplatin (10 mg/kg body weight) and i.p. with NAC (250 mg/kg body weight) for three consecutive days. Nephrotoxicity was determined by plasma BUN and creatinine levels. In tissue samples, myeloperoxidase (MPO), nuclear factor-kappa B (NF-kB), high mobility group box-1 (HMGB-1), total oxidant status (TOS), and total antioxidant status (TAS) levels were measured. Kidneys were analyzed histopathologically as well.

Results

It was revealed that cisplatin was not effective on MPO, HMGB-1 and NF-kB levels but did increase TOS levels and decrease TAS levels in tissue samples. Interestingly, NAC elevated MPO and HMGB-1 levels significantly. Nevertheless, NAC ameliorated histological and functional changes in kidney tissues.

Conclusion

It is suggested that inflammation has a limited effect on cisplatin nephrotoxicity in this experimental design, and, as reflected by decreased BUN and creatinine levels, NAC can be used as an additional therapeutic agent in standard cisplatin treatment protocols.

Relation of maternal vitamin D status with gestational diabetes mellitus and perinatal outcome

OBJECTIVE

To investigate the relationship between maternal vitamin D status and glucose intolerance, and its impact on pregnant women and their newborns.

METHODS

A cohort of pregnant women were divided into three groups: women with gestational diabetes mellitus, ones with normal results both after the 50 gr and 100 gr OGTT (CG-1) and ones having a positive result after the 50 gr OGTT screening but negative results for gestational diabetes mellitus (GDM) after the 100 gr OGTT (CG-2).

RESULTS

The newborn length in CG-1 was greater than in GDM and CG-2 (p= 0.002 and p= 0.02). Fasting blood glucose and insulin resistance (IR) were negatively correlated with length of the newborns (r=-0.3, p=0.03 and r=-0.3, p=0.01). The newborns of women with GDM had lower APGAR-1 and 5 scores than those of CG-1 and CG-2 (APGAR-1 p= 0.001 and p= 0.004, APGAR-5 p=0.005 and p=0.007, respectively). APGAR scores were correlated negatively with IR (APGAR-1 r=-0.32, p=0.01, APGAR-5 r=-0.3, p=0.03) and positively with 25OHD levels (APGAR-1 r=0.3, p=0.01, APGAR-5 r=0.3, p=0.02).

CONCLUSION

Vitamin D deficiency, gestational diabetes and insulin resistance are interrelated. Severe vitamin D deficiency during pregnancy is associated with poor pregnancy and neonatal outcome.